Skip to main content
Premium Trial:

Request an Annual Quote

NHGRI Plans to Fund Pediatric eMERGE Genomics Studies

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The National Human Genome Research Institute expects to publish an announcement this summer that will offer funding opportunities to investigators using pediatric genome-wide genotyping data to join in the second phase of the Electronic Medical Records and Genomic Research (eMERGE) Network.

NHGRI said this week that it wants researchers with expertise and insights in conducting genomic research in pediatric biorepositories with electronic medical records to begin thinking about applying for the new funding opportunity.

The aim of the initiative will be to build upon the eMERGE Network's Phase I experience in defining phenotypes from electronic medical records, conducting genome-wide association studies, reducing privacy risks, and developing community consultation procedures, and to incorporate those lessons into pediatric genomics research and clinical care.

These research areas could involve expanding the eMERGE electronic phenotyping library, expanding eMERGE sites to include children and under-represented minorities, and incorporating genome-wide association genotyping information into EMRs in order to improve genetic risk assessment, prevention, diagnosis, treatment, and accessibility of genomic medicine.

The Scan

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.

Machine Learning Improves Diagnostic Accuracy of Breast Cancer MRI, Study Shows

Combining machine learning with radiologists' interpretations further increased the diagnostic accuracy of MRIs for breast cancer, a Science Translational Medicine paper finds.

Genome Damage in Neurons Triggers Alzheimer's-Linked Inflammation

Neurons harboring increased DNA double-strand breaks activate microglia to lead to neuroinflammation like that seen in Alzheimer's disease, a new Science Advances study finds.

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.